In hepatocellular carcinoma, overexpressing IGF1R promotes cell proliferation, migration, and antiapoptosis through the PI3K/AKT and extracellular regulated protein kinase pathways, contributing to sorafenib resistance.44 This evidence concerns the gene IGF1R and hepatocellular carcinoma.